Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Renzapride in Women With IBS-C
NCT00607971Phase 3Terminated
- Sponsor
- Alizyme
- Start
- Apr 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of renzapride in irritable bowel syndrome (IBS), sponsored by Alizyme. Started Apr 2006; status: terminated.
02
Drugs
renzapride
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00607971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00607971.